Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Federal Trade Commission
Fuji
Cerilliant
Argus Health
AstraZeneca
QuintilesIMS
US Department of Justice
Farmers Insurance

Generated: January 18, 2018

DrugPatentWatch Database Preview

RITODRINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ritodrine hydrochloride and what is the scope of ritodrine hydrochloride freedom to operate?

Ritodrine hydrochloride
is the generic ingredient in three branded drugs marketed by Abraxis Pharm, Hospira, and Astrazeneca, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ritodrine hydrochloride.
Medical Subject Heading (MeSH) Categories for RITODRINE HYDROCHLORIDE

US Patents and Regulatory Information for RITODRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071618-001 Feb 28, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071619-001 Feb 28, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071188-001 Jul 23, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca YUTOPAR ritodrine hydrochloride TABLET;ORAL 018555-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071189-001 Jul 23, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER ritodrine hydrochloride INJECTABLE;INJECTION 071438-001 Jan 22, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for RITODRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca YUTOPAR ritodrine hydrochloride TABLET;ORAL 018555-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Moodys
Baxter
Deloitte
Dow
Medtronic
US Army
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot